Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders??? Deficit

v3.22.2
Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Deficit - USD ($)
Total
Series B Redeemable Convertible Preferred Stock
Series B-1 Redeemable Convertible Preferred Stock
Series U-1 Redeemable Convertible Preferred Stock
Series U-2 Redeemable Convertible Preferred Stock
Common stock
Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit
Previously Reported
Previously Reported
Common stock
Previously Reported
Additional paid-in capital
Previously Reported
Accumulated other comprehensive income
Previously Reported
Accumulated deficit
Revision of Prior Period, Adjustment
Revision of Prior Period, Adjustment
Common stock
Revision of Prior Period, Adjustment
Additional paid-in capital
Beginning balance at Dec. 31, 2018 $ 89,639,000                 $ 89,639,000         $ 0    
Beginning balance (in shares) at Dec. 31, 2018 129,773,238                 59,780,210         69,993,028    
Increase (Decrease) in Temporary Equity [Roll Forward]                                  
Issuance of redeemable convertible preferred stock, net of issuance costs   $ 633,966,000                              
Issuance of redeemable convertible preferred stock, net of issuance costs (in shares)   150,105,995                              
Issuance of redeemable convertible preferred stock in relation to acquisition   $ 21,259,000 $ 18,951,000                            
Issuance of redeemable convertible preferred stock in relation to acquisition (in shares)   4,994,432 5,551,965                            
Ending balance at Dec. 31, 2019 $ 763,815,000                 $ 763,815,000              
Ending balance (in shares) at Dec. 31, 2019 290,425,630                 290,425,630              
Beginning balance (in shares) at Dec. 31, 2018           244,741,973         112,740,624         132,001,349  
Beginning balance at Dec. 31, 2018 $ (24,260,000)         $ 2,000 $ 2,975,000   $ (27,237,000) $ (24,260,000) $ 11,000 $ 2,966,000   $ (27,237,000)   $ (9,000) $ 9,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Issuance of common stock in relation to acquisitions $ 6,933,000                                
Issuance of common stock in relation to acquisitions (in shares) 3,984,965                                
Issuance of common stock upon exercise of stock options (in shares)           1,469,408                      
Issuance of common stock upon exercise of stock options $ 318,000           318,000                    
Vesting of early exercised stock options 603,000           603,000                    
Vesting of early exercised stock options (in shares)           3,381,311                      
Vesting of restricted stock           $ 1,000 (1,000)                    
Vesting of restricted stock (in shares)           10,537,369                      
Cancellation of restricted stock (542,710)                                
Stock-based compensation 28,133,000           28,133,000                    
Unrealized loss on held for sale investments 125,000             $ 125,000                  
Net loss (94,077,000)               (94,077,000)                
Ending balance (in shares) at Dec. 31, 2019           263,572,316         263,572,316            
Ending balance at Dec. 31, 2019 (82,225,000)         $ 3,000 38,961,000 125,000 (121,314,000) $ (82,225,000) $ 3,000 $ 38,961,000 $ 125,000 $ (121,314,000)      
Increase (Decrease) in Temporary Equity [Roll Forward]                                  
Repurchase of series redeemable convertible preferred stock   $ (532,000)                              
Repurchase of series B redeemable convertible preferred stock (in shares)   (125,083)                              
Ending balance at Dec. 31, 2020 $ 763,283,000                                
Ending balance (in shares) at Dec. 31, 2020 290,300,547                                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Issuance of common stock upon exercise of stock options (in shares)           3,433,498                      
Issuance of common stock upon exercise of stock options $ 2,952,000           2,952,000                    
Vesting of early exercised stock options 388,000           388,000                    
Vesting of early exercised stock options (in shares)           2,262,645                      
Vesting of restricted stock (in shares)           9,542,168                      
Stock-based compensation 16,880,000           16,880,000                    
Unrealized loss on held for sale investments (125,000)             (125,000)                  
Net loss (214,449,000)               (214,449,000)                
Ending balance (in shares) at Dec. 31, 2020           278,810,627                      
Ending balance at Dec. 31, 2020 (276,579,000)         $ 3,000 59,181,000 0 (335,763,000)                
Increase (Decrease) in Temporary Equity [Roll Forward]                                  
Issuance of redeemable convertible preferred stock, net of issuance costs         $ 397,862,000                        
Issuance of redeemable convertible preferred stock, net of issuance costs (in shares)         44,174,944                        
Issuance of redeemable convertible preferred stock in relation to acquisition       $ 1,000,000,000                          
Issuance of redeemable convertible preferred stock in relation to acquisition (in shares)       110,437,359                          
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization $ (2,161,145,000)                                
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization (in shares) (444,912,850)                                
Ending balance at Dec. 31, 2021 $ 0                                
Ending balance (in shares) at Dec. 31, 2021 0                                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Issuance of common stock in relation to acquisitions $ 937,668,000         $ 3,000 937,665,000                    
Issuance of common stock in relation to acquisitions (in shares)           257,863,127                      
Purchase consideration allocated to non-cash compensation expense 7,873,000           7,873,000                    
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization (in shares)           444,912,850                      
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization 2,161,145,000         $ 4,000 2,161,141,000                    
Issuance of common stock upon the reverse recapitalization, net of issuance costs 1,040,521,000         $ 1,000 1,040,520,000                    
Issuance of common stock upon the reverse recapitalization, net of issuance costs (in shares)           129,294,175                      
Issuance of common stock upon exercise of stock options (in shares)           8,393,301                      
Issuance of common stock upon exercise of stock options 7,847,000           7,847,000                    
Issuance of common stock upon vesting of restricted stock units (in shares)           917,959                      
Common stock withheld for net share settlement of equity awards (in shares)           (302,418)                      
Common stock withheld for net share settlement of equity awards (3,705,000)           (3,705,000)                    
Vesting of early exercised stock options 182,000           182,000                    
Vesting of early exercised stock options (in shares)           1,271,075                      
Vesting of restricted stock (in shares)           1,669,118                      
Stock-based compensation 222,203,000           222,203,000                    
Net loss (755,453,000)               (755,453,000)                
Ending balance (in shares) at Dec. 31, 2021           1,122,829,814                      
Ending balance at Dec. 31, 2021 $ 3,341,702,000         $ 11,000 $ 4,432,907,000 $ 0 $ (1,091,216,000)